Abiomed, based in Danvers, Massachusetts, is a venture capital fund specializing in health tech and manufacturing. They invest in Series A companies with check sizes ranging from $500,000 to $10 million. Notable investments include Protembis. Abiomed aims to support advancements in circulatory support and oxygenation medical technologies.